Lichao Zhang

Lichao Zhang has extensive work experience in the field of biotechnology and pharmaceuticals. Lichao is currently serving as a Principal Scientist II at EpiBiologics and a Consultant at Stanford University, both roles starting in 2023. Prior to this, they were a Senior Scientist at Harpoon Therapeutics for the entirety of 2022. From 2019 to 2022, they worked as a Mass Spectrometry Platform Scientist at CZ Biohub. Lichao also held the position of Staff Scientist at Stanford University from 2014 to 2019. Their early career includes an internship at Regeneron Pharmaceuticals, Inc. in 2012.

Lichao Zhang completed a Bachelor of Science (BS) degree in Chemistry at Nankai University from 2005 to 2009. Subsequently, from 2009 to 2014, they pursued a PhD in Chemistry at the University of Virginia.